SCHEMBL24264347

SCHEMBL24264347

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5cccc6oc7ccccc7c56)cc34)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
HCRTR1 O43613 1/20 0.37
CHEK2 O96017 1/20 0.36
PLA2G2A P14555 2/20 0.36
PLA2G4A P47712 2/20 0.36
PLA2G10 O15496 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
AHR P35869 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
PRKDC P78527 1/20 0.35
MMP12 P39900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23821762 0.99 PLA2G2A (0.37) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL23821786 0.98 ALOX5 (0.38) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL25019332 0.97 ALDH1A1 (0.38) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL22329530 0.97 ALDH1A1 (0.38) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL22329684 0.97 ALDH1A1 (0.38) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL24216897 0.97 ALOX5 (0.39) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL24264343 0.97 ALOX5 (0.39) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL24216792 0.97 ALOX5 (0.39) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL24097367 0.97 ALOX5 (0.39) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A
SCHEMBL21926382 0.97 ALOX5 (0.39) ALOX5HCRTR1CHEK2PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 ALOX5 1152/4885HCRTR1 470/4885CHEK2 2134/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 ALOX5 1152/4885HCRTR1 470/4885CHEK2 2134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.